Ginkgo Bioworks Holdings Inc (NYSE:DNA)

$ 9.66 -0.56 (-5.48%) Market Cap: 587.43 Mil Enterprise Value: 367.95 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 37/100

Q3 2024 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Nov 12, 2024

$8.39 (-4.22%)

Earnings
Q2 2024 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Aug 08, 2024

$11.43 (+4.15%)

Earnings
Q4 2023 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Feb 29, 2024

$60.8

Earnings
Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Nov 08, 2023

$59.6 (-3.25%)

Earnings
Ginkgo Bioworks Holdings Inc Investor Day Transcript
Oct 03, 2023
Ginkgo Bioworks Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Ginkgo Bioworks Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 15, 2023
Q2 2023 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Aug 09, 2023

$80.4 (-3.37%)

Earnings
Ginkgo Bioworks Holdings Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
Q1 2023 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
May 10, 2023

$54 (-1.46%)

Earnings
Codexis Inc, Ginkgo Bioworks Holdings Inc and Twist Bioscience Corp at TD Cowen Health Care Conference- Panel Transcript
Mar 06, 2023
Q4 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Mar 01, 2023

$56 (-4.76%)

Earnings
Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Nov 14, 2022

$107.2 (-5.96%)

Earnings
Q2 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Aug 15, 2022

$139.6 (-3.86%)

Earnings
Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript
Jul 25, 2022
Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript
Jul 25, 2022
Ginkgo Bioworks Holdings Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
Ginkgo Bioworks Holdings Inc at William Blair Growth Stock Conference Transcript
Jun 09, 2022
Q1 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
May 16, 2022

$97.2 (-8.65%)

Earnings
Q4 2021 Ginkgo Bioworks Holdings Inc Earnings Presentation Transcript
Mar 28, 2022
Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Q3 2021 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Nov 15, 2021

Earnings

Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript

Jul 25, 2022 / 09:00PM GMT

Release Date Price: $111.2 (-4.79%)

Transcript

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Zymergen Business Update Conference Call. (Operator Instructions)

I would now like to turn the conference to your host, Ms. Carrie Mendivil with Investor Relations. Please go ahead.

Carrie Mendivil

Thank you. Earlier today, Zymergen issued a joint press release with Ginkgo Bioworks announcing a definitive merger agreement for Ginkgo to acquire Zymergen. Joining me today to discuss this announcement as well as other organizational updates is Jay Flatley, acting Chief Executive Officer of Zymergen.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.

Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release Ginko Bioworks

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.